Vimkunya Disease Interactions
There is 1 disease interaction with Vimkunya (chikungunya vaccine, recombinant (cvx 329)).
Vaccines (inactivated)/toxoids (applies to Vimkunya) immunodeficiency
Moderate Potential Hazard, Moderate plausibility.
The expected serum antibody responses may not be obtained when vaccines and/or toxoids are administered to patients with primary or acquired immunodeficiency, including those with severe combined immunodeficiency, hypogammaglobulinemia or agammaglobulinemia, HIV infection, altered immune states (due to diseases such as leukemia, lymphoma, or generalized malignancy), or immunosuppression due to drug or other treatments (e.g., corticosteroids, alkylating agents, antimetabolites, or radiation).
Switch to professional interaction data
Vimkunya drug interactions
There are 304 drug interactions with Vimkunya (chikungunya vaccine, recombinant (cvx 329)).
Report options
More about Vimkunya (chikungunya vaccine, recombinant (cvx 329))
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
